Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack
Superseded by The Medical Letter "Potassium Iodide for Thyroid Protection in a Nuclear Accident" - Issue 1361, April 4, 2011
Potassium iodide (KI) taken orally before or at the time of exposure can limit or prevent uptake of radioactive iodine by the thyroid gland. Children, adolescents and young adults who as children were exposed to even small amounts of radioiodine from the Chernobyl reactor accident have had a marked increase, beginning 4 years after exposure, in the incidence of thyroid nodules and cancer (FDA Guidance Document)....
Potassium iodide (KI) taken orally before or at the time of exposure can limit or prevent uptake of radioactive iodine by the thyroid gland. Children, adolescents and young adults who as children were exposed to even small amounts of radioiodine from the Chernobyl reactor accident have had a marked increase, beginning 4 years after exposure, in the incidence of thyroid nodules and cancer (FDA Guidance Document)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1143
Article Code: 1143c
Date: November 11, 2002
Volume: 44
Pages: 97-98
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1143
Article Code: 1143c
Date: November 11, 2002
Volume: 44
Pages: 97-98
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)